Study title:
McClain-K, Heise-R, Day-D-L, Lee-C-K-K, Woods-G, Aeppli-D.
Department of Pediatrics, The University of Minnesota School of Medicine, Minneapolis, MN, United States.
Hodgekin's disease in children: Correlation of clinical characteristics, staging procedures, and treatment at the university of Minnesota.
American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR-HEMATOL-ONCOL}, 1990, Vol/Iss/Pg. 12/2 (147-154), ISSN: 0192-8562.McClain-K, Heise-R, Day-D-L, Lee-C-K-K, Woods-G, Aeppli-D.
Department of Pediatrics, The University of Minnesota School of Medicine, Minneapolis, MN, United States.
Hodgekin's disease in children: Correlation of clinical characteristics, staging procedures, and treatment at the university of Minnesota.
American Jo...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|